Flagship Pioneering and its portfolio companies are in line to receive up to $720 million in milestones for each of the 10 programs that GSK could option.
The trial results, published at the Alzheimer’s Association International Conference, provided the first glimpse of how GLP-1 drugs may act on hard-to-treat brain disorders.
Revita is an outpatient endoscopic procedure that involves resurfacing the mucosal lining of the duodenum, the first part of the small intestine just after the stomach, which is responsible for breaking down food into absorbable nutrients.
The COVID-19 vaccine maker’s cancer drug candidate BNT111 showed significant improvement in the response rate in patients with advanced melanoma during a Phase 2 trial, the German company said on Tuesday.
This new integrated approach marries the rich patient support experience offered in Inizio Engage’s Patient solutions services with the advanced analytics and data integration of Nye Health’s digital platform to provide programs that truly resonate with patients and their care partners to ultimately improve patient outcomes.
The combination therapy is one step closer to becoming a potential new first-line standard of care for patients with unresectable or metastatic urothelial carcinoma in Europe.